Sponsor or institution

Clinical trials and research at STCube, Inc.

• 2Clinical trials
• 1Country

All recruiting trials (2)

• Nelmastobart plus docetaxel for advanced non-small cell lung cancer

  This trial tests nelmastobart combined with docetaxel in people with advanced non-small cell lung cancer who are resistant or intolerant to platinum chemotherapy or immunotherapy.

  Recruiting at 5 sites Phase 2 STCube, Inc. · Gyeonggi-do and 4 other locations · NCT07306624

• Nelmastobart plus trifluridine/tipiracil and bevacizumab for metastatic or recurrent colorectal cancer

  This trial tests whether adding nelmastobart to trifluridine/tipiracil and bevacizumab helps adults with metastatic or recurrent colorectal cancer who cannot use oxaliplatin or irinotecan.

  Recruiting Phase 1/2 STCube, Inc. · Seongnam-si, Gyeonggi-do and 4 other locations · NCT06873763

Quick answers

How many clinical trials run by STCube, Inc. are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in South Korea. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →